End points
| . | No. of events . | Estimate . | 95% CI, % . | |
|---|---|---|---|---|
| Cumulative incidence of aGVHD at 100 days | ||||
| Any grade | 28 | 39.0% | 28.1 | 49.6 |
| Grades 2-4 | 14 | 18.2% | 10.6 | 27.6 |
| Grades 3-4 | 5 | 6.5% | 3.1 | 15.1 |
| Cumulative incidence of cGVHD at 12 months | ||||
| Any grade | 10 | 13.4% | 6.9 | 22.1 |
| Moderate/severe | 7 | 9.4% | 4.1 | 17.2 |
| Cumulative incidence of relapse at 12 months | 18 | 23.8% | 14.9 | 33.9 |
| Cumulative incidence of NRM at 12 months | 7 | 9.1% | 4.0 | 16.9 |
| GRFS at 12 months | 33 | 55.3% | 43.4 | 65.7 |
| OS at 12 months | 16 | 78.6% | 67.4 | 86.3 |
| . | No. of events . | Estimate . | 95% CI, % . | |
|---|---|---|---|---|
| Cumulative incidence of aGVHD at 100 days | ||||
| Any grade | 28 | 39.0% | 28.1 | 49.6 |
| Grades 2-4 | 14 | 18.2% | 10.6 | 27.6 |
| Grades 3-4 | 5 | 6.5% | 3.1 | 15.1 |
| Cumulative incidence of cGVHD at 12 months | ||||
| Any grade | 10 | 13.4% | 6.9 | 22.1 |
| Moderate/severe | 7 | 9.4% | 4.1 | 17.2 |
| Cumulative incidence of relapse at 12 months | 18 | 23.8% | 14.9 | 33.9 |
| Cumulative incidence of NRM at 12 months | 7 | 9.1% | 4.0 | 16.9 |
| GRFS at 12 months | 33 | 55.3% | 43.4 | 65.7 |
| OS at 12 months | 16 | 78.6% | 67.4 | 86.3 |